Gamma Oryzanol

Studies Conducted On

Gamma Oryzanol Preventing The Cytokine Storm In COVID-19 Patients

Year of Study: 2021

Title of the Study: Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19

Findings from this study suggest that gamma oryzanol can be considered a coadjutant therapy to prevent the cytokine storm in COVID-19 patients with obesity conditions.

Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452242/